Clinical Trial Update: Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis [NA]

View source ↗

Summary

A terminated clinical trial comparing nebulized 3% hypertonic saline to standard of care in bronchiolitis with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Drugs mentioned

• Nebulized 3% hypertonic saline (3% hypertonic saline)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Bronchiolitis | NA | Status: TERMINATED | Results posted: 2020-02-11